Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03020888 · ClinicalTrials.gov registry record · NA
Magseed Magnetic Marker Localization
A NA study, sponsored by Endomagnetics.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT03020888 is a NA study that has completed, run by Endomagnetics. The registered enrollment target is 120 participants.
The verdict
NCT03020888, a NA study, has completed, sponsored by Endomagnetics.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The purpose of this post-marketing study is to provide prospective evidence that the Magseed and Sentimag® is effective for lesion localization in patients undergoing surgical excision of a breast lesion and to summarize measures of product safety and performance.
Interventions
- DEVICE Magseed and Sentimag
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2017-01 |
| Est. Completion | 2018-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03020888
The ClinicalTrials.gov registry entry for NCT03020888 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endomagnetics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magseed and Sentimag is the first listed.
NCT03020888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03020888 about?
NCT03020888 is a clinical study titled "Magseed Magnetic Marker Localization". The purpose of this post-marketing study is to provide prospective evidence that the Magseed and Sentimag® is effective for lesion localization in patients undergoing surgical excision of a breast lesion and to summarize measures of product safety and performance.
What is the current status of trial NCT03020888?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2017-01. Estimated completion is 2018-07.
What interventions are being tested in trial NCT03020888?
The interventions under investigation include: Magseed and Sentimag (DEVICE).
Who is sponsoring clinical trial NCT03020888?
This trial is sponsored by Endomagnetics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.